Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Virtual Event

18 ago 2020 8:00 a.m. - 19 ago 2020 3:45 p.m.

(US Eastern Standard Time)

Fort Washington, PA 19034

Digital Technology in Clinical Trials

Session 1 Track 2: Current and Emerging Technologies

Session Chair(s)

Keith  Wenzel

Keith Wenzel

Volunteer

DIA Study Endpoints Community, United States

Despite being a risk adverse industry, the Life Sciences Industry currently has a stable of tried and true technologies which have been embraced and generate value, but we find ourselves beset by literal barrage of new technologies some of which show signs of promise, some where the jury is still out and others yet untested, but intriguing. This session will include two presentations on Current and Emerging Technologies followed by a panel discussing the state of play for digital technology and the trends and concepts around the next generation of tried and true technologies as well as the potential benefits of emerging technology.

Learning Objective :

At the conclusion of this session, participants should be able to:

  • Understand how currently accepted and adopted technology is evolving to deliver additional benefits
  • Have a view to emerging technologies and their respective place along the adoption curve

Speaker(s)

Stephen  Ruhmel, MPH

Speaker

Stephen Ruhmel, MPH

Janssen Research & Development, United States

Clinical Innovation Lead

Keith  Wenzel

Speaker

Keith Wenzel

DIA Study Endpoints Community, United States

Volunteer

Paul  Upham

Panelist

Paul Upham

Roche / Genentech, United States

Head, Smart Devices

Bill  Byrom, PhD

Bill Byrom, PhD

Signant Health , United Kingdom

Vice President, Product Intelligence and Positioning; Principal, eCOA Science

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.